I still have a v. small amount - just in case their research comes to fruition-
"Research and Development
Rockeby’s research and development activities are undertaken at the company’s laboratory in Perth, Australia.
Female Healthcare represents a core specialization and Rockeby currently markets two products for diagnosis of fungal infections in women and is actively developing two further diagnostic products for use in maternal health one for diagnosis of Premature Rupture of Amniotic Membrane (PROM) and the other for diagnosis of Pre Eclampsia."
RBY Price at posting:
0.0¢ Sentiment: Hold Disclosure: Not Held
